Progyny Inc. (PGNY)
NASDAQ (NGS) NASDAQ (NGS) Primary Summary
Progyny Sees Utilization Rebound as Early Renewals De-Risk Outlook
Progyny NASDAQ: PGNY CEO Pete Anevski said the company expects member engagement and utilization to rebound following a more pronounced summer seasonal slowdown, while early renewal and new-client commitments have increased management's confidence in its outlook for the remainder of the year.
Progyny Q2 Earnings Call Highlights
Progyny NASDAQ: PGNY reported record quarterly revenue, gross profit and adjusted EBITDA for the second quarter of 2026, while management said early sales commitments and client-retention activity have positioned the company favorably for the 2027 selling season.
Progyny, Inc. (PGNY) Q2 2026 Earnings Call Transcript
Progyny, Inc. (PGNY) Q2 2026 Earnings Call Transcript
Progyny Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 93 | $2,001.36 | $2,895.09 | $893.73 | 44.66% |
 Curtis Ellergodt Rothschild Investment LLC | 300 | $5,679.23 | $9,411 | $3,731.77 | 65.71% |
| ABB Alexander Bjornager Bonde Danske Bank A/S | 528,717 | $10.32M | $14.87M | $4.55M | 44.08% |
| SN Stephanie Nee HARBOR CAPITAL ADVISORS Inc. | 201 | $3,668.14 | $5,648.1 | $1,979.96 | 53.98% |
| BG Bart Gancher Intech Investment Management LLC | 44,657 | $1.14M | $1.26M | $118,942.03 | 10.46% |
Progyny Inc. (PGNY) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Progyny Inc. ever had a stock split?
Progyny Inc. Profile
| Health Care Technology Industry | Healthcare Sector | Pete Anevski CEO | NASDAQ (NGS) Exchange | 74340E103 CUSIP |
| US Country | 846 Employees | - Last Dividend | - Last Split | 25 Oct 2019 IPO Date |
Overview
Progyny, Inc. is a pioneering benefits management company in the United States, dedicated to offering fertility and family building benefits solutions. Initially founded as Auxogyn, Inc. in 2008, the company underwent a rebranding to Progyny, Inc. in 2015, marking a significant pivot in its mission to support individuals and couples on their journey to parenthood. With its headquarters in New York, New York, Progyny stands out for its comprehensive approach to fertility benefits, integrating personalized support with access to a selective network of fertility specialists.
Products and Services
- Fertility Benefits Solution
This solution is designed to offer a differentiated benefits plan design that caters to the unique needs of each member. Progyny's approach encompasses personalized concierge-style member support services, ensuring that members receive tailored guidance throughout their fertility journey. Additionally, the company prides itself on its selective network of fertility specialists, aimed at providing high-quality care and improving outcomes for its members.
- Progyny Rx
Understanding the crucial role of medications in fertility treatments, Progyny offers an integrated pharmacy benefits solution, Progyny Rx. This service ensures that members have seamless access to the necessary medications throughout their treatment, aiming to alleviate one of the stressors that individuals and couples face during this challenging time.
- Assistance Service Programs
To further support its members' diverse family building needs, Progyny introduces various assistance service programs. These programs are designed to offer support beyond traditional fertility treatments and can include reimbursement for adoption, surrogacy, doula services, and travel expenses needed to receive medical services. These comprehensive offerings underscore Progyny's commitment to supporting all paths to parenthood.
